This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit August 21, 2014

   NAMCP   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Fall Managed Care Forum
Nov. 13-14, 2014
Bellagio Hotel
Las Vegas Nevada


Click here to visit the conference website.

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

 



Fall Managed Care Forum 2014

The Fall Forum will feature the first Annual Innovation Awards for the NAMCP Medical Directors Institute, AAMCN and AAIHDS. If you are interested in applying for this award, please contact Katie Eads at keads@namcp.org or 804-527-1905 and we will send you an application.

The Fall Forum will be held November, 12-13, 2014 at the Bellagio Resort in Las Vegas, Nevada for medical directors, nurses and administrators.

The Forum features up-to-date, useful information on the ACA and healthcare changes, trends and how to improve patient outcomes.

Click here to see the agenda, speakers, register and for more information on the conference.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




GENOMICS


Screening for new breast cancer genes leaves women with tough choices
The Boston Globe
After Angelina Jolie revealed that she carried a breast cancer gene mutation last year, the number of women seeking genetic screening for breast cancer has surged — what some oncologists have referred to as the “Angelina Jolie” effect. Jolie carried a BRCA1 mutation and was told she had a 50 to 70 percent chance of developing breast cancer, a risk she deemed high enough to warrant having a preventive double mastectomy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Our genes determine the traces that stress leaves behind on our brains
Medical Xpress
Our individual genetic make-up determines the effect that stress has on our emotional centers. These are the findings of a group of researchers from the MedUni Vienna. Not every individual reacts in the same way to life events that produce the same degree of stress. Some grow as a result of the crisis, whereas others break down and fall ill, for example with depression.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Cancer and the secrets of your genes
The New York Times
On Aug. 6, researchers announced in The New England Journal of Medicine that they had found that mutations in a gene called PALB2 greatly increase the risk of breast cancer. This is one of the biggest developments since the discovery in the ’90s of the role of mutations in the BRCA1 and BRCA2 genes in breast and ovarian cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Blood expression levels of genes targeted by stress hormones could be biomarker for developing PTSD
News-Medical.net
Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing post-traumatic stress disorder, according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Now Available


CLICK HERE to learn more about Orenitram.



Orenitram is a trademark of United Therapeutics. © 2014 United Therapeutics.
US/ORE/JUN14/038 All rights reserved.
 


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


DNA sequencing spots genetic key to lupus
Bioscience Technology
Medical researchers have used DNA sequencing to identify a gene variant responsible for causing lupus in a young patient. The development shows that, for the first time, it is feasible for researchers to identify the individual causes of lupus in patients by using DNA sequencing, allowing doctors to target specific treatments to individual patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Acute myeloid leukemia drugmaker closes $14.2M, focuses on personalized medicine
MedCity News
Tolero Pharmaceuticals, a Salt Lake City, Utah drug developer, has set its sights on ramping up the commercialization and development efforts of its acute myeloid leukemia treatment, which will enter phase 3 trial sometime next year. The company’s fresh off of closing a series B round of $14.2 million, though the initial aim for the company was to raise $35 million.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New thinking needed for superbug treatments
By Mike Wokasch
Not a day goes by without reading or hearing about the seemingly impossible task of finding effective new treatments against "superbugs" that are resistant to existing drugs. The dearth of prospects for treating these superbugs is often blamed on the lack of investment and market economics. Sure, more investment-friendly healthcare market opportunities might lure additional pharma companies and money to the effort, but there is an even bigger factor standing in the way of conquering this medical dilemma.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


REGENERATIVE MEDICINE


Stem cells can help rebuild joints
The Huffington Post
Harnessing stem cells to cure disease is the hottest topic in injury and arthritis treatment today. By stimulating the adult stem cells found in our own bodies, we can amplify and speed up the natural healing process as well as grow new bone and cartilage to rebuild joints without the need for artificial replacements.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Stemedica posts Alzheimer's stem cell data
Drug Discovery & Development
Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells in a preclinical animal model of Alzheimer’s disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




EMERGING MEDICAL TECHNOLOGIES


Machine that keeps lungs alive outside body tested
USA Today
Creamy-pink and glistening, they lie on a stainless steel exam table — this pair of lungs inflating and falling in a rhythmic, ghostly pattern. At the University of Michigan, researchers are pushing the limits of medicine, eking out new ways to boost the numbers of organs that are available to thousands of patients who die every year waiting for them.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New medical technology poses safety problems if users not trained properly
Modern Healthcare via Crain's Detroit Business
When clinical staff at a MedStar Health hospital near Washington misunderstood a confusing pop-up box on a digital blood-sugar reader in 2011, they mistakenly gave insulin to a patient with low blood sugar, which caused her to go into a diabetic coma. Hospital staff had earlier made a seemingly minor customization to the glucometer, which led to the error.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Our genes determine the traces that stress leaves behind on our brains
Medical Xpress
Our individual genetic make-up determines the effect that stress has on our emotional centers. These are the findings of a group of researchers from the MedUni Vienna.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Newly discovered gene mutation raises breast cancer risk to 35 percent by age 70
Healthline
Mutations in two genes, BRCA1 and BRCA2, were known to raise a woman's risk of breast cancer long before Angelina Jolie’s now famous double mastectomy.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Is musical talent rooted in genes?
LiveScience via Fox News
Practice doesn't always make perfect when it comes to becoming the next Mozart, a new study suggests.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


FDA: NEW TREATMENTS AND TECHNOLOGY


The growing threat of antibiotic resistance
By Rosemary Sparacio
A number of diseases once easily treatable have become resistant to antibiotics currently on the market, and that number continues to grow. Tom Frieden, director of the Centers for Disease Control and Prevention, has warned that antibiotic resistance is such a serious problem that it could be the "next pandemic." Obviously, the growth of antibiotic-resistant pathogens means that more and more cases emerge where standard treatments no longer work, infections become more difficult to control, and the risk of spreading infections to others is increased — especially when hospital stays are prolonged.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA approves Biogen Idec's multiple sclerosis drug
The Boston Globe
Scrambling to stay ahead of the competition in bringing multiple sclerosis drugs to market, Biogen Idec Inc. won U.S. regulatory approval to sell a new type of injectable drug that treats adults with the most common form of the neurodegenerative disease. Food and Drug Administration regulators approved the Cambridge biotech’s application to market the drug, called Plegridy, as a longer-lasting treatment for U.S. patients with relapsing-remitting multiple sclerosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drug may reverse hair loss in alopecia patients
TIME
A drug normally used to treat bone marrow disorders may help patients suffering from alopecia, according to a new study. Alopecia areata is a kind of autoimmune disorder that causes the immune system T-cells to attack hair follicles, causing them to fall out and become dormant.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


Survey: ACOs continue to face obstacles with health IT adoption
iHealthBeat
Accountable care organizations have not made substantial progress in health IT adoption over the past year, according to a preliminary data released by the eHealth Initiative, Health Data Management reports. The data are based off of the first 62 responses to the national 2014 survey of ACOs, which aims to evaluate how ACOs in commercial and federal markets are using health IT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Hospital-run ACOs do not work, says physician
Health Data Mangement
The Palm Beach Accountable Care Organization has reported $22 million in savings in its first year, and member doctors received total returns of $11 million — success that the ACO attributes to the fact that it is physician-owned and physician-run. "Physicians need to run ACOs," said Lenny Sukienik, M.D., the Palm Beach ACO's medical director. "If you have a hospital running an ACO, it won't work."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Health insurance benefits — can you have it your way?
Forbes
As the percentage of large employers that consider a shift to defined contribution and/or private exchange increases, the number of options — and flexibility in those options — must also increase. Consideration for those options rose last year from 14 percent to 18 percent among large employers. Further, those who are considering the move to a private exchange want to because of their desire to offer more and better plan options, as well as realize cost-savings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


What the US healthcare system can learn from Ebola outbreak
NPR
Jeanine Thomas is a well-known patient advocate and active member of ProPublica's Patient Harm Facebook Community. But recently, she contributed in another forum: the World Health Organization. The WHO selected Thomas to serve on the ethics committee that recommended making experimental drugs available to Ebola patients in West Africa. Thomas was the sole patient representative on the international panel, which decided that offering experimental drugs is ethical if patients give fully informed consent and data are gathered to track the safety and effectiveness of the medications used.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Apple, Google face hurdles entering healthcare
CBS MoneyWatch
When Apple announced new features for its next iOS mobile operating system in June, it was clear that the healthcare industry was a big target. The tech giant is also reportedly talking with major healthcare organizations about how they might use the company's so-called HealthKit services. Google and other large tech players are also in the race to dominate the emerging business for health and fitness software and hardware.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Is Ebola airborne? Canadian study shows deadly evidence (By Lauren Swan)
An aging America: The future of healthcare depends on telehealth (By Karen R. Thomas)
Medicare offers waiver of 3-day rule for some ACOs, bundled payments (Modern Healthcare)
Deloitte: Global e-visits to reach 100M by year's end (FierceHealthIT)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
August 14, 2014
August 7, 2013
July 31, 2014
July 24, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063